194 related articles for article (PubMed ID: 34166375)
1. Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Fukai J; Iwadate Y; Kajiwara K; Hondoh H; Yamanaka R
PLoS One; 2021; 16(6):e0251272. PubMed ID: 34166375
[TBL] [Abstract][Full Text] [Related]
2. GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.
Takashima Y; Hamano M; Fukai J; Iwadate Y; Kajiwara K; Kobayashi T; Hondoh H; Yamanaka R
Sci Rep; 2020 May; 10(1):8435. PubMed ID: 32439996
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.
Takashima Y; Hamano M; Yoshii K; Hayano A; Fukai J; Iwadate Y; Kajiwara K; Hondoh H; Yamanaka R
Int J Clin Oncol; 2023 Mar; 28(3):468-481. PubMed ID: 36607476
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
PLoS One; 2019; 14(1):e0210400. PubMed ID: 30615673
[TBL] [Abstract][Full Text] [Related]
5. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
PLoS One; 2020; 15(2):e0229577. PubMed ID: 32101576
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL.
Takashima Y; Kawaguchi A; Sato R; Yoshida K; Hayano A; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Nakano M; Ogawa S; Tashiro K; Yamanaka R
Sci Rep; 2019 Jul; 9(1):10004. PubMed ID: 31292525
[TBL] [Abstract][Full Text] [Related]
7. Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patients.
Barakat M; Albitar M; Whitney R; Abdulhaq H
Cancer Treat Res Commun; 2021; 27():100310. PubMed ID: 33581493
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
Braggio E; Van Wier S; Ojha J; McPhail E; Asmann YW; Egan J; da Silva JA; Schiff D; Lopes MB; Decker PA; Valdez R; Tibes R; Eckloff B; Witzig TE; Stewart AK; Fonseca R; O'Neill BP
Clin Cancer Res; 2015 Sep; 21(17):3986-94. PubMed ID: 25991819
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes.
Zhou Y; Liu W; Xu Z; Zhu H; Xiao D; Su W; Zeng R; Feng Y; Duan Y; Zhou J; Zhong M
Neoplasia; 2018 Oct; 20(10):1059-1069. PubMed ID: 30227305
[TBL] [Abstract][Full Text] [Related]
11. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and cell of origin subtyping using gene expression profiling in HIV-negative patients with primary central nervous system lymphoma.
Hilal T; Maguire A; Kosiorek HE; Rimsza LM; Rosenthal AC
Leuk Lymphoma; 2019 Dec; 60(14):3581-3583. PubMed ID: 31246148
[No Abstract] [Full Text] [Related]
13. Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition.
Jiménez I; Carabia J; Bobillo S; Palacio C; Abrisqueta P; Pagès C; Nieto JC; Castellví J; Martínez-Ricarte F; Escoda L; Perla C; Céspedes Torrez DH; Boix J; Purroy N; Puigdefàbregas L; Seoane J; Bosch F; Crespo M
J Neurooncol; 2020 Aug; 149(1):13-25. PubMed ID: 32691208
[TBL] [Abstract][Full Text] [Related]
14. Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphoma.
He J; Wu J; Jiao Y; Rodriguez FJ; Blakeley JO; Kinzler KW; Papadopoulos N; Vogelstein B; Holdhoff M
J Neurooncol; 2013 Sep; 114(3):275-9. PubMed ID: 23828278
[TBL] [Abstract][Full Text] [Related]
15. The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.
Alame M; Cornillot E; Cacheux V; Rigau V; Costes-Martineau V; Lacheretz-Szablewski V; Colinge J
Theranostics; 2021; 11(8):3565-3579. PubMed ID: 33664848
[No Abstract] [Full Text] [Related]
16. Insights into the biology of primary central nervous system lymphoma.
Mrugala MM; Rubenstein JL; Ponzoni M; Batchelor TT
Curr Oncol Rep; 2009 Jan; 11(1):73-80. PubMed ID: 19080745
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.
Bruno A; Labreche K; Daniau M; Boisselier B; Gauchotte G; Royer-Perron L; Rahimian A; Lemoine F; de la Grange P; Guégan J; Bielle F; Polivka M; Adam C; Meyronet D; Figarella-Branger D; Villa C; Chrétien F; Eimer S; Davi F; Rousseau A; Houillier C; Soussain C; Mokhtari K; Hoang-Xuan K; Alentorn A
Neuro Oncol; 2018 Jul; 20(8):1092-1100. PubMed ID: 29432597
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in primary central nervous system lymphoma (PCNSL).
Takeuchi H; Matsuda K; Kitai R; Sato K; Kubota T
J Neurooncol; 2007 Sep; 84(2):141-5. PubMed ID: 17406788
[TBL] [Abstract][Full Text] [Related]
19. Characterization of genomic alterations in primary central nervous system lymphomas.
Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia is associated with poor survival in primary central nervous system lymphoma patients.
Debata A; Yoshida K; Ujifuku K; Yasui H; Kamada K; Niino D; Matsuo T
Tumori; 2017 May; 103(3):272-278. PubMed ID: 28058711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]